Lupin Ltd. NSE: LUPIN | BSE: 500257

Mid-range Performer

Download real time

2046.60 15.40 (0.76%)

479.3K

NSE+BSE Volume

NSE 18 Sep, 2025 3:31 PM (IST)

US FDA Observation

Lupin receives Form 483 with six observations from the US FDA for its Nagpur injectable facility See details

Lupin Ltd. quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents